Description

Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility.

Resources

Name	Format	Description	Link
Notice – Release of ICH S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/safety/notice-ich-s5-r3-detection-toxicity-reproduction-medicinal-products-toxicity-male-fertility.html
Notice – Release of ICH S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/international-conference-harmonisation/innocuite/avis-ich-s5-r3-detection-toxicite-reproduction-fertilite-males-produits-pharmaceutiques-destines-humains.html

Tags

Topics

Categories